Platinum-induced ototoxicity
MONDO:0800178Progressive, bilateral, and irreversible sensorineural hearing loss as a frequently encountered side effect of platinum-based chemotherapy such as cisplatin and carboplatin.
Also known as: deafness, platinum-induced, platinum-related ototoxicity
7 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
Can charcoal speed up poison recovery? new study aims to find out
Disease control Recruiting nowThis pilot study is testing whether giving activated charcoal within 6 hours of swallowing a poisonous substance can prevent the poison from getting worse and shorten hospital stays. About 100 adults and children who have ingested a substance that charcoal can absorb will be rand…
Phase: PHASE4 • Sponsor: Laval University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Hope for cancer patients: drug may shield ears from chemo damage
Prevention Recruiting nowThis study tests whether acetylcysteine, a drug often used for other purposes, can prevent hearing loss caused by cisplatin chemotherapy. About 40 adults receiving high-dose cisplatin will get either acetylcysteine or a placebo after each chemo session. Researchers will measure h…
Phase: PHASE2 • Sponsor: Siriraj Hospital • Aim: Prevention
Last updated Jun 27, 2026 08:13 UTC
-
Ear gel may shield cancer patients from Chemo-Induced deafness
Prevention Recruiting nowThis study tests whether injecting a special gel (sodium thiosulfate) into the ear before each round of cisplatin chemotherapy can prevent hearing loss. About 100 adults with head and neck cancer will receive the gel in one ear only, so the treated ear can be compared to the untr…
Phase: PHASE3 • Sponsor: The Netherlands Cancer Institute • Aim: Prevention
Last updated Jun 27, 2026 08:04 UTC